Bellevue Group’s Encompass Health EHC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$951K Sell
9,829
-9,260
-49% -$950K 0.02% 92
2025
Q4
$2.03M Sell
19,089
-103,869
-84% -$12M 0.04% 96
2025
Q3
$15.6M Sell
122,958
-8,783
-7% -$1.05M 0.32% 54
2025
Q2
$16.2M Sell
131,741
-41,137
-24% -$4.7M 0.36% 52
2025
Q1
$17.5M Sell
172,878
-15,644
-8% -$1.53M 0.39% 54
2024
Q4
$17.4M Buy
188,522
+169,289
+880% +$16.6M 0.34% 69
2024
Q3
$1.86M Buy
19,233
+5,365
+39% +$482K 0.03% 107
2024
Q2
$1.19M Sell
13,868
-1,112
-7% -$93.3K 0.02% 117
2024
Q1
$1.24M Buy
14,980
+3,080
+26% +$226K 0.02% 117
2023
Q4
$794K Buy
+11,900
New +$771K 0.01% 126

Other funds holding EHC

Bellevue Group's EHC Position: Q1 2026 in Review

Bellevue Group reduced its Encompass Health (EHC) stake by 49% in Q1 2026, selling an estimated $950K and leaving 9,829 shares worth $951K. The position accounts for 0.02% of the portfolio, ranked #92.

Bellevue Group first reported a position in EHC in Q4 2023 and has held it in 10 quarters since. The position peaked at $17.5M in Q1 2025. 577 funds tracked by Wall St. Rank hold EHC as of Q1 2026.

  • Bellevue Group held 9,829 shares of Encompass Health worth $951K as of Q1 2026.
  • Bellevue Group sold 9,260 Encompass Health shares in Q1 2026, an estimated $950K.
  • Encompass Health made up 0.02% of Bellevue Group's portfolio in Q1 2026, its #92 holding.
  • Bellevue Group first reported a position in Encompass Health in Q4 2023 and has held it in 10 quarters since.
  • Bellevue Group's Encompass Health position peaked at $17.5M in Q1 2025.
  • 577 funds tracked by Wall St. Rank held Encompass Health as of Q1 2026.

Based on Bellevue Group's 13F filing for Q1 2026, filed 15 May 2026.